CR20120614A - Derivados de amino-tropano - Google Patents
Derivados de amino-tropanoInfo
- Publication number
- CR20120614A CR20120614A CR20120614A CR20120614A CR20120614A CR 20120614 A CR20120614 A CR 20120614A CR 20120614 A CR20120614 A CR 20120614A CR 20120614 A CR20120614 A CR 20120614A CR 20120614 A CR20120614 A CR 20120614A
- Authority
- CR
- Costa Rica
- Prior art keywords
- lower alkyl
- amino
- tropan
- derivatives
- tropan derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención, se refiere a compuestos de la fórmula general I, en donde, R1, R2 y R3, son, de una forma independiente la una con respecto a la otra, hidrógeno, alquilo inferior, alcoxi inferior, cicloalquilo, alquilo inferior sustituido por halógeno, ó S-alquilo inferior; o a sales de adición de ácidos, farmacéuticamente aceptables, a una mezcla racémica, o sus correspondientes enantiómeros y / o isómeros ópticos de ésta.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10166757 | 2010-06-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20120614A true CR20120614A (es) | 2013-01-11 |
Family
ID=44310862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20120614A CR20120614A (es) | 2010-06-22 | 2012-12-05 | Derivados de amino-tropano |
Country Status (24)
Country | Link |
---|---|
US (1) | US8153653B2 (es) |
EP (1) | EP2585456B1 (es) |
JP (1) | JP5546684B2 (es) |
KR (1) | KR101445016B1 (es) |
CN (1) | CN102947297B (es) |
AR (1) | AR081961A1 (es) |
AU (1) | AU2011269145A1 (es) |
BR (1) | BR112012032576A2 (es) |
CA (1) | CA2801458C (es) |
CL (1) | CL2012003552A1 (es) |
CO (1) | CO6630160A2 (es) |
CR (1) | CR20120614A (es) |
EA (1) | EA201291374A1 (es) |
EC (1) | ECSP12012347A (es) |
ES (1) | ES2550831T3 (es) |
HK (1) | HK1179606A1 (es) |
IL (1) | IL222998A0 (es) |
MA (1) | MA34251B1 (es) |
MX (1) | MX2012013820A (es) |
PE (1) | PE20130317A1 (es) |
SG (1) | SG186329A1 (es) |
TW (1) | TWI417097B (es) |
WO (1) | WO2011161006A1 (es) |
ZA (1) | ZA201209248B (es) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU228356B1 (en) * | 1996-02-22 | 2013-03-28 | Neurosearch As | Tropane-derivatives, inhibiting neurotransmitter re-uptake, their preparation, pharmaceutical compositions containing them and use of the compounds |
US5834484A (en) * | 1997-03-12 | 1998-11-10 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Cocaine analogs |
NZ545454A (en) * | 2003-09-09 | 2009-11-27 | Hoffmann La Roche | 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
FR2861076B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique |
CA2564501A1 (en) * | 2004-04-29 | 2005-11-24 | Merck Sharp & Dohme Limited | Azetidine glycine transporter inhibitors |
FR2873693B1 (fr) * | 2004-07-29 | 2006-09-15 | Sanofi Synthelabo | Derives d'amino-tropane, leur preparation et leur application en therapeutique |
GB0428231D0 (en) * | 2004-12-23 | 2005-01-26 | Glaxo Group Ltd | Compounds |
RU2007125380A (ru) * | 2005-01-06 | 2009-02-20 | Ф. Хоффманн-Ля Рош Аг (Ch) | Сульфанил-замещенные фенилметаноны в качестве ингибиторов переносчика глицина 1 (glyt-1) для лечения неврологических и психоневрологических заболеваний |
EP2121622A1 (en) * | 2007-02-01 | 2009-11-25 | Glaxo Group Limited | Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
WO2010020548A1 (en) * | 2008-08-20 | 2010-02-25 | F. Hoffmann-La Roche Ag | Glyt1 receptor antagonists |
-
2011
- 2011-06-15 US US13/160,559 patent/US8153653B2/en not_active Expired - Fee Related
- 2011-06-17 KR KR1020127033182A patent/KR101445016B1/ko active IP Right Grant
- 2011-06-17 CA CA2801458A patent/CA2801458C/en not_active Expired - Fee Related
- 2011-06-17 CN CN201180030703.3A patent/CN102947297B/zh active Active
- 2011-06-17 PE PE2012002444A patent/PE20130317A1/es not_active Application Discontinuation
- 2011-06-17 EP EP11728224.4A patent/EP2585456B1/en active Active
- 2011-06-17 MA MA35398A patent/MA34251B1/fr unknown
- 2011-06-17 JP JP2013515816A patent/JP5546684B2/ja not_active Expired - Fee Related
- 2011-06-17 BR BR112012032576A patent/BR112012032576A2/pt active Search and Examination
- 2011-06-17 EA EA201291374A patent/EA201291374A1/ru unknown
- 2011-06-17 AU AU2011269145A patent/AU2011269145A1/en not_active Abandoned
- 2011-06-17 ES ES11728224.4T patent/ES2550831T3/es active Active
- 2011-06-17 WO PCT/EP2011/060073 patent/WO2011161006A1/en active Application Filing
- 2011-06-17 MX MX2012013820A patent/MX2012013820A/es active IP Right Grant
- 2011-06-17 SG SG2012091708A patent/SG186329A1/en unknown
- 2011-06-20 TW TW100121503A patent/TWI417097B/zh not_active IP Right Cessation
- 2011-06-21 AR ARP110102138A patent/AR081961A1/es unknown
-
2012
- 2012-10-26 CO CO12192372A patent/CO6630160A2/es active IP Right Grant
- 2012-11-12 IL IL222998A patent/IL222998A0/en unknown
- 2012-12-05 CR CR20120614A patent/CR20120614A/es unknown
- 2012-12-06 ZA ZA2012/09248A patent/ZA201209248B/en unknown
- 2012-12-17 CL CL2012003552A patent/CL2012003552A1/es unknown
- 2012-12-20 EC ECSP12012347 patent/ECSP12012347A/es unknown
-
2013
- 2013-06-05 HK HK13106598.8A patent/HK1179606A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA201209248B (en) | 2013-08-28 |
KR20130029414A (ko) | 2013-03-22 |
MA34251B1 (fr) | 2013-05-02 |
ECSP12012347A (es) | 2013-01-31 |
EA201291374A1 (ru) | 2013-06-28 |
IL222998A0 (en) | 2013-02-03 |
AR081961A1 (es) | 2012-10-31 |
PE20130317A1 (es) | 2013-03-11 |
ES2550831T3 (es) | 2015-11-12 |
TW201206438A (en) | 2012-02-16 |
CA2801458C (en) | 2018-10-30 |
CN102947297B (zh) | 2015-12-16 |
JP5546684B2 (ja) | 2014-07-09 |
CL2012003552A1 (es) | 2013-04-12 |
US8153653B2 (en) | 2012-04-10 |
EP2585456A1 (en) | 2013-05-01 |
WO2011161006A1 (en) | 2011-12-29 |
AU2011269145A1 (en) | 2012-11-08 |
US20110312993A1 (en) | 2011-12-22 |
TWI417097B (zh) | 2013-12-01 |
SG186329A1 (en) | 2013-01-30 |
CN102947297A (zh) | 2013-02-27 |
EP2585456B1 (en) | 2015-09-16 |
CO6630160A2 (es) | 2013-03-01 |
JP2013529607A (ja) | 2013-07-22 |
MX2012013820A (es) | 2013-01-28 |
KR101445016B1 (ko) | 2014-09-26 |
BR112012032576A2 (pt) | 2016-11-22 |
CA2801458A1 (en) | 2011-12-29 |
HK1179606A1 (zh) | 2013-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY33227A (es) | Compuestos de pirrolopirimidina como inhibidores de la cdk4/6 | |
UY33226A (es) | Compuestos de pirrolopirimidina deuterada como inhibidores de la cdk4/6 | |
AU2012313888A8 (en) | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH | |
AR082154A1 (es) | DERIVADOS DE PIRAZOLO[1,5-a]PIRIMIDINA COMO MODULADORES DE IRAK4 | |
CR20120053A (es) | Compuestos y metodos inhibidores de jak de pirazolopirimidina | |
CR20140238A (es) | Derivados nucleósidos con sustitución 2´, 4´- difluoro-2´-metilo como inhibidores de la replicación del arn del vhc | |
CR20140042A (es) | Indazoles | |
CO6541606A2 (es) | Espiroindolinona- pirrolidinas | |
CO6831982A2 (es) | Pirazolo[4,3-d]pirimidinas útiles como inhibidores de cinasas | |
CR20130369A (es) | Novedosos derivados heterocíclicos | |
EA201101147A1 (ru) | Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
CL2010000253A1 (es) | Procedimiento de preparacion de ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable; y uno de los compuestos intermediarios considerados. | |
CR20130476A (es) | Derivados de pirazolidin-3-ona | |
CR20110275A (es) | 3-aminociclopentancarboxamidas como moduladores del receptor quimiocina | |
EA201391206A1 (ru) | Способы синтеза производных предшественника молибдоптерина z | |
ECSP13012548A (es) | Inhibidores de oxadiazol de la producción de leucotrienos. | |
CR20150158A (es) | Derivados de etinilo como moduladores de receptor de actividad mglur5 | |
EA201200123A1 (ru) | Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
EA201000397A1 (ru) | Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
ME00929B (me) | NOVI POSTUPAK ZA DOBlJANJE KRISTALNOG OBLIKA V AGOMELATIN A | |
MX2013009386A (es) | Nuevos compuestos de azaespirodecanona. | |
CY1120784T1 (el) | Νεα κρυσταλλικη μορφη | |
UA113223C2 (xx) | Арилетинілпіримідини | |
CR20150143A (es) | Derivados de etinilo como moduladores del receptor de actividad mglur5 | |
CR20120614A (es) | Derivados de amino-tropano |